Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain

被引：46

作者：

Bedaiwy, Mohamed A.

Casper, Robert F. ^{[1
]}

机构：

[1] Univ Toronto, Div Reprod Sci, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada

[2] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

来源：

FERTILITY AND STERILITY | 2006年 / 86卷 / 01期

关键词：

D O I：

10.1016/j.fertnstert.2005.12.030

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This pilot study examined the effect of a low-dose E and pulsed progestogen hormone therapy (HT) regimen for add-back during long-term GnRH-agonist therapy on bone mineral density (BMD) in five patients with stage IV endometriosis. Bone mineral density was stable after initiation of HT for the entire follow-up period (up to 10 years). One patient stopped her treatment on two occasions to conceive and was successful each time with delivery of a normal baby. No patient had return of pelvic pain after HT add-back.

引用

页码：220 / 222

页数：3

共 50 条

[21] COMPARISON OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST GOSERELIN ACETATE ALONE VERSUS GOSERELIN COMBINED WITH ESTROGEN-PROGESTOGEN ADD-BACK THERAPY IN THE TREATMENT OF ENDOMETRIOSIS
KIILHOLMA, P
KORHONEN, M
TUIMALA, R
HAGMAN, E
KIVINEN, S
FERTILITY AND STERILITY, 1995, 64 (05) : 903 - 908
[22] LONG-TERM MEDICAL THERAPY FOR LEIOMYOMATA UTERI - A PROSPECTIVE, RANDOMIZED STUDY OF LEUPROLIDE ACETATE DEPOT PLUS EITHER ESTROGEN-PROGESTIN OR PROGESTIN ADD-BACK FOR 2 YEARS
FRIEDMAN, AJ
DALY, M
JUNEAUNORCROSS, M
GLEASON, R
REIN, MS
LEBOFF, M
HUMAN REPRODUCTION, 1994, 9 (09) : 1618 - 1625
[23] The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age
Shin, So-Young
Min, Jung-Ae
Yoon, Byung-Koo
Bae, Duk Soo
Choi, Doo Seok
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 133 (01): : 90 - 94
[24] Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain (Retraction of vol 60, pg 236, 1993)
Friedman, AJ
Hornstein, MD
FERTILITY AND STERILITY, 1996, 65 (01) : 211 - 211
[25] Fertility Outcomes After Laparoscopic Cystectomy in Infertile Patients with Stage III–IV Endometriosis: a Cohort with 6–10 years of Follow-up
Ting-Ting Sun
Si-Kai Chen
Xiao-Yan Li
Jun-Ji Zhang
Yi Dai
Jing-Hua Shi
Shuang-Zheng Jia
Yu-Shi Wu
Jin-Hua Leng
Advances in Therapy, 2020, 37 : 2159 - 2168
[26] Development of a symptom-based, screening tool for early-stage endometriosis in patients with chronic pelvic pain
Yeung, Patrick, Jr.
Bazinet, Caroline
Gavard, Jeffrey A.
JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2014, 6 (04) : 174 - 189
[27] ADD BACK THERAPY USE AMONG ENDOMETRIOSIS PATIENTS INITIATING LEUPROLIDE ACETATE (LA) THERAPY: ASSOCIATION WITH IMPROVED ADHERENCE AND LOWER SURGERY RATES IN A COHORT OF COMMERCIALLY INSURED WOMEN
Soliman, A. M.
Bonafede, M. M.
Farr, A. M.
Castelli-Haley, J.
Winkel, C.
VALUE IN HEALTH, 2015, 18 (03) : A104 - A104
[28] Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients
Verma, Alka
Konje, Justin C.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 143 (02) : 112 - 115
[29] Homeopathic Treatment of Patients With Chronic Low Back Pain A Prospective Observational Study With 2 Years' Follow-up
Witt, Claudia M.
Luedtke, Rainer
Baur, Roland
Willich, Stefan N.
CLINICAL JOURNAL OF PAIN, 2009, 25 (04): : 334 - 339
[30] The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age
Han, Yi
Zou, Shi-En
Long, Qi-Qi
Zhang, Shao-Fen
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (07): : 583 - 588

← 1 2 3 4 5 →